Filter Results
:
(179)
Show Results For
- All HBS Web (179)
- Faculty Publications (13)
Show Results For
- All HBS Web (179)
- Faculty Publications (13)
- April 2021
- Article
Utilizing Time-driven Activity-based Costing to Determine Open Radical Cystectomy and Ileal Conduit Surgical Episode Cost Drivers
By: Janet Baack Kukreja, Mohamed A. Seif, Marissa W. Merry, James R. Incalcaterra, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Thomas W. Feeley and Neema Navai
Objectives
Patients undergoing radical cystectomy represent a particularly resource-intensive patient population. Time-driven activity based costing (TDABC) assigns time to events and then costs are based on the people involved in providing care for specific... View Details
Patients undergoing radical cystectomy represent a particularly resource-intensive patient population. Time-driven activity based costing (TDABC) assigns time to events and then costs are based on the people involved in providing care for specific... View Details
Keywords:
Time-Driven Activity-Based Costing;
Value-based Healthcare;
Health Care and Treatment;
Cost;
Cost vs Benefits;
Analysis
Kukreja, Janet Baack, Mohamed A. Seif, Marissa W. Merry, James R. Incalcaterra, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Thomas W. Feeley, and Neema Navai. "Utilizing Time-driven Activity-based Costing to Determine Open Radical Cystectomy and Ileal Conduit Surgical Episode Cost Drivers." Urologic Oncology: Seminars and Original Investigations 39, no. 4 (April 2021).
- 22 Aug 2005
- Research & Ideas
Balancing the Future Against Today’s Needs
wagon wheel factory after the car has been invented.—Alex Urquhart, GE Commercial Finance This has been a critical motivational point for Phanstiel at PacifiCare. When the company unveiled its growth plans...
View Details
Keywords:
by Paul Michelman
- 16 Aug 2011
- Working Paper Summaries
Managing Political Risk in Global Business: Beiersdorf 1914-1990
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Testing and Trials;
Health Care and Treatment;
Business Model;
Problems and Challenges;
Pharmaceutical Industry;
Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Care and Treatment;
Business Model;
Leadership;
Pharmaceutical Industry;
Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Care and Treatment;
Business Model;
Production;
Business Strategy;
Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
- 06 Sep 2019
- Blog Post
The Business of Medicine: MD/MBA Students Having an Impact
investigation with market research to evaluate access to cancer biopsy devices in East Africa. With her dual degree, Wagner plans to continue her work in health care delivery and her career in improving...
View Details
- 15 Apr 2014
- First Look
First Look: April 15
Purchase this case: http://hbr.org/product/pepsico-profits-and-food-the-belt-tightens/an/314055-PDF-ENG Harvard Business School Case 313-012 Cancer Treatment Centers of America® (A) Cancer Treatment Centers...
View Details
Keywords:
Sean Silverthorne
- 28 Nov 2005
- Research & Ideas
Unilever: Transformation and Tradition
for major innovations. The science base was high quality and deep. Research on animal feeds could lead over time into a successful pregnancy test. Unilever's knowledge about edible fats and detergents was second to none in the world. This...
View Details
- Research Summary
Health-care Applications
Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details
- 27 Aug 2013
- First Look
First Look: August 27
Factory Models for Cancer Care This case compares and contrasts four different models for delivering View Details
Keywords:
Sean Silverthorne
- 27 Sep 2011
- First Look
First Look: September 27
the salience of information is a central determinant of a firm's demand function, even for purchases as large as college attendance. Download the paper: http://www.hbs.edu/research/pdf/12-014.pdf Measuring Teamwork in Health View Details
Keywords:
Sean Silverthorne
- 05 Oct 2009
- Research & Ideas
The Vanguard Corporation
striking. It shows the trust and respect these companies have for their people. By giving staff certain goals they need to meet, as well as work on teams that may cut across many parts of the business, employees are motivated very...
View Details
Keywords:
by Sean Silverthorne
- Web
Curriculum - MBA
companies, start-up biotechnology and life science companies, consulting with a focus on biotech/life sciences, policy/ government, or investing focused on biotechnology and life sciences. Second Year Fall Term Entrepreneurship in the...
View Details
- 11 May 2009
- Research & Ideas
The IT Leader’s Hero Quest
Rising star Jim Barton has decidedly mixed feelings after being selected as the new chief information officer at the fictional IVK Corporation. On the one hand, he lacks an IT background; on the other, he's ambitious and up for a...
View Details
Keywords:
by Martha Lagace
- Web
Faculty & Advisors - MBA
University; SB/SM, Massachusetts Institute of Technology Chris leads MPM Capital’s public market investing as portfolio manager for BioImpact Equities (formerly known as Burrage Capital) and the Oncology Impact Funds. Previously, Chris...
View Details
- 26 Jun 2020
- Research & Ideas
Why Japanese Businesses Are So Good at Surviving Crises
disaster. Niinami’s managers tracked down staff members by foot, securing them housing in hotels, finding supplies for displaced workers, and assuring franchisees whose stores were destroyed that they didn’t need to worry about finances....
View Details
Keywords:
by Dina Gerdeman
- 17 Feb 2022
- Book
When Employees Feel a Sense of Purpose, Companies Succeed
success by focusing on delivering not only for their shareholders and customers but also for their employees, communities, and the environment. In the video below, I speak with...
View Details
Keywords:
by Ranjay Gulati
- 09 Jan 2018
- First Look
First Look at New Research and Ideas, January 9, 2018
multidisciplinary treatment of head and neck cancers. Methods: Four prospective treatment-based bundles were developed for patients with selected head and neck cancers. These risk-adjusted bundles covered 1 year of View Details
Keywords:
Sean Silverthorne
- 09 Feb 2010
- First Look
First Look: Feb. 9
"high-end" firm that is expected to care only for its most quality-sensitive customers can have an advantage in introducing a product relative to a firm that is expected to be more widely...
View Details
Keywords:
Martha Lagace